Skip to main content
Welcome
Preliminary Program
Registration
Accomodation
Venue
Contact
Program
Home
/
Preliminary Program
Day
- Any -
Monday, 29th May
Tuesday, 30th May
Wednesday, 31st May
Type
- Any -
Almuerzo
Sesiones
Talleres
Monday, 29th May
DEFINITION, EPIDEMIOLOGY, BASIC MECHANISMS
16:15
h -
16:30
h
Welcome and Introduction
Jose M Serratosa Fernández.
Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Manuel Toledo Argany.
Hospital Universitario Vall d'Hebron, Barcelona, Spain
16:30
h -
17:00
h
Epidemiology and social impact of DRE
Manuel Toledo Argany.
Hospital Universitario Vall d'Hebron, Barcelona, Spain
17:00
h -
17:30
h
What is DRE? Concept and definitions
17:30
h -
18:00
h
Basic mechanisms of drug-resistance
18:00
h -
18:30
h
Roundtable and discussion “What is DRE?”
Tuesday, 30th May
FOCAL EPILEPSIES
08:30
h -
09:15
h
Can we predict DRE early in the focal epilepsies?
09:15
h -
10:00
h
Can we avoid DRE with early interventions?
Elinor Ben-Menachem.
Sahlgrenska Academym University of Gothenburg, Gothenburg, Sweden
10:00
h -
10:30
h
Optimal pharmacological treatment of DRE
Felix Rosenow.
Epilepsy Center Frankfurt Rhine-Main. Center of Neurology and Neurosurgery. Goethe-University Frankfurt, Frankfurt, Germany
10:30
h -
11:00
h
Break
11:00
h -
12:00
h
Symposium
FUTURE ASMs AND THERAPIES
12:00
h -
12:30
h
ASMs under development
12:30
h -
13:00
h
Future therapies
Jose M Serratosa Fernández.
Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
13:00
h -
14:00
h
Lunch
IDIOPATHIC GENERALIZED EPILEPSIES
14:00
h -
14:30
h
Drug resistance in IGEs: clinical characteristics
Javier Salas Puig.
Hospital Universitario Vall d'Hebron, Barcelona, Spain
14:30
h -
15:00
h
Treatment of drug resistant IGEs
15:00
h -
15:30
h
Treatment of autoimmune epilepsies
Mar Carreño.
Hospital Clínic, Barcelona, Spain
15:30
h -
16:00
h
Break
16:00
h -
17:00
h
Symposium
Wednesday, 31st May
DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES (DEEs)
08:30
h -
09:00
h
Clinical characteristics of the main types of DEEs
Elena Gardella.
Danish Epilepsy Center. University of Copenhagen. Copenhagen, Denmark.
09:00
h -
09:30
h
Treatment of Dravet disease and Lennox-Gastaut syndrome
09:30
h -
10:00
h
Treatment of other DEEs
Stephan Auvin.
Robert Debré Hospital, Public Hospital Network of Paris, Paris, France
10:00
h -
10:30
h
Break
10:30
h -
11:30
h
Symposium
SPECIAL LECTURE
11:30
h -
12:15
h
Comorbidities, mortality, and SUDEP in DRE
Torbjörn Thompson.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
12:15
h -
12:45
h
Comprehensive evaluation test
12:45
h -
13:00
h
Conclusions and awards
Jose M Serratosa Fernández.
Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Manuel Toledo Argany.
Hospital Universitario Vall d'Hebron, Barcelona, Spain